ISRCTN95702682已完成未知
The PARTNERS2 Study: Trial of primary care based collaborative care for people with a diagnosis of schizophrenia, or bipolar or other types of psychosis
Birmingham and Solihull Mental Health Foundation Trust0 个研究点目标入组 198 人开始时间: 2017年10月26日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 198
研究概览
简要总结
2019 Other publications in https://www.ncbi.nlm.nih.gov/pubmed/30616552 qualitative formative evaluation (added 20/11/2019) 2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/33785568/ (added 27/10/2022) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33583478/ epidemiological medical records review (added 21/11/2023) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37078520/ outcome measures (added 21/11/2023)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Registered with a participating GP practice
- •2. Aged 18 years and over
- •3. A clinical diagnosis of schizophrenia, bipolar, or other types of psychosis schizoaffective disorder (including lifetime and current) or has evidence of chronic psychoses [care clusters 11 and 12]
排除标准
- •1. Inability to understand and complete questionnaires
- •2. Inability to understand English (or access to translation services)
- •3. Inability to give informed consent
- •4. Currently receiving crisis care or care in a secure setting
研究者
相似试验
已完成
2 期
Quicksilver: a study to assess the safety of a new MRI approach to pre-operatively stage rectal cancer and guide treatmentRectal cancerCancerISRCTN05107772Mount Sinai Hospital (Canada)82
进行中（未招募）
2 期
A phase II trial of Cediranib in the treatment of patients with Alveolar Soft Part SarcomaSarcomaCancerAlveolar soft part sarcomaISRCTN63733470The Institute of Cancer Research/Royal Marsden Hospital NHS Foundation Trust (UK)48
已完成
不适用
Evaluation of benefits of the CAREGIVERSPRO-MMD platform giving support and assistance to people living with dementia and their primary caregiverMild cognitive impairment or dementia (mild to moderate)Mental and Behavioural DisordersUnspecified dementiaISRCTN15654731niversitat Politècnica de Catalunya-BarcelonaTech (UPC)1,204
招募中
2 期
Tislelizumab Combined With Chemotherapy With or Without Bevacizumab in TKI-Resistant EGFR-Mutated Non-squamous NSCLCNon Small Cell Lung CancerNCT04405674Shanghai Chest Hospital120
招募中
2 期
Dalpiciclib Plus AI (Neoadjuvant Endocrine Therapy) Compared With Neoadjuvant Chemotherapy in Early Breast Cancer （EBC）Breast CancerNCT06107673Hebei Medical University Fourth Hospital144